tiprankstipranks
Trending News
More News >
COSCIENS Biopharma (CSCIF)
OTHER OTC:CSCIF
US Market
Advertisement

COSCIENS Biopharma (CSCIF) Ownership - Who Owns COSCIENS Biopharma?

Compare
908 Followers

COSCIENS Biopharma (CSCIF) Ownership Overview

<0.01%100.00%
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
The ownership structure of COSCIENS Biopharma (CSCIF) stock is a mix of institutional, retail, and individual investors. , and 100.00% is owned by Public Companies and Individual Investors.
The ownership structure of COSCIENS Biopharma (CSCIF) stock is a mix of institutional, retail, and individual investors. , <0.01% is owned by Insiders

Top Shareholders

Holder
# of Shares
Type
% Holding
Value

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns COSCIENS Biopharma (CSCIF)?
Currently, no data Available
What percentage of COSCIENS Biopharma (CSCIF) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of COSCIENS Biopharma (CSCIF) stock is held by institutional investors.
    What percentage of COSCIENS Biopharma (CSCIF) stock is held by retail investors?
    According to the latest TipRanks data, approximately 100.00% of COSCIENS Biopharma (CSCIF) stock is held by retail investors.
      Who owns the most shares of COSCIENS Biopharma (CSCIF)?
      Currently, no data Available
      What is the significance of the ownership structure for a publicly traded company?
      The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis